WideMed has an agreement with MedNet GmbH to represent the company in Europe.
WideMed Ltd. (TASE:WDMD) has applied for EU CE Mark marketing certification for its Morpheus sleep monitor. The monitor is a computerized system for measuring and diagnosing apnea and other sleep disorders.
WideMed has an agreement with MedNet GmbH to represent the company in Europe.
WideMed's share rose 8.8% today to NIS 1.15, giving a market cap of NIS 14 million, after fluctuating sharply in recent sessions.
Published by Globes [online], Israel business news - www.globes-online.com - on July 19, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010